Don't miss SGLT Tools - PowerPoint slide library for SGLT2 inhibitors

Glomerulonephritis

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

ernando C. Fervenza, M.D., Ph.D., Gerald B. Appel, M.D., Sean J. Barbour, M.D., Brad H. Rovin, M.D., Richard A. Lafayette, M.D., Nabeel Aslam, M.D., Jonathan A. Jefferson, M.D., Patrick E. Gipson, M.D., Dana V. Rizk, M.D., John R. Sedor, M.D., James F. Si
https://www.ncbi.nlm.nih.gov/pubmed/31269364
Google Plus
LinkedIn

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

Ayoub I, Hebert L Rovin BH
N Engl J Med. 2015 Dec 3;373(23):2225-36
Google Plus
LinkedIn

Ten common mistakes in the management of lupus nephritis

Bose B, Silverman ED, Bargman JM
Am J Kidney Dis. 2014 Apr;63(4):667-76. doi: 10.1053/j.ajkd.2013.10.056. Epub 2013 Dec 12
Google Plus
LinkedIn

Efficacy of remission-induction regimens for ANCA-associated vasculitis

Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH; RAVE-ITN Research Group.
N Engl J Med. 2013 Aug 1;369(5):417-27
Google Plus
LinkedIn

IgA nephropathy

Wyatt RJ, Julian BA
N Engl J Med. 2013 Jun 20;368(25):2402-14
Google Plus
LinkedIn

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the lupus nephritis assessment with rituximab study (LUNAR)

Rovin BH, Furie R, Latinis K, Looney RJ, Fervenza FC, Sanchez-Guerrero J, Maciuca R, Zhang D, Garg JP, Brunetta P, Appel G; LUNAR Investigator Group
Arthritis Rheum. 2012 Apr;64(4):1215-26
Google Plus
LinkedIn

Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis

Appel GB, Contreras G, Dooley MA, Ginzler EM, Isenberg D, Jayne D, Li LS, Mysler E, Sánchez-Guerrero J, Solomons N, Wofsy D; Aspreva Lupus Management Study Group
J Am Soc Nephrol. 2009 May;20(5):1103-12
Google Plus
LinkedIn

The classification of glomerulonephritis in systemic lupus erythematosus revisited

Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M
J Am Soc Nephrol. 2004 Feb;15(2):241-50
Google Plus
LinkedIn

A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group
N Engl J Med. 2003 Jul 3;349(1):36-44
Google Plus
LinkedIn

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group
N Engl J Med. 2003 Jul 3;349(1):36-44
Google Plus
LinkedIn

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, Lau CS, Wong AK, Tong MK, Chan KW, Lai KN
N Engl J Med. 2000 Oct 19;343(16):1156-62
Google Plus
LinkedIn

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

Mark F. Gourley, MD; Howard A. Austin III, MD; Dorothy Scott, MD; Cheryl H. Yarboro, RN; Ellen M. Vaughan, RN; Joanne Muir, RN; Dimitrios T. Boumpas, MD; John H. Klippel, MD; James E. Balow, MD; and Alfred D. Steinberg, MD
Ann Intern Med. 1996 Oct 1;125(7):549-57
Google Plus
LinkedIn

Glomerulonephritis

Donald E. Hricik, M.D., Moonja Chung-Park, M.D., and John R. Sedor, M.D.
N Engl J Med 1998; 339:888-899
Google Plus
LinkedIn

ukidneyisup